Pfizer shuffles R&D leadership to prepare for Seagen merger

Pfizer is reorganizing its research leadership team, assigning additional duties to Chief Scientific Officer Mikael Dolsten, M.D., PhD., while bidding farewell to Chief Development Officer William Pao, M.D., PhD., who just took on the role in February 2022.